Can I Take Mounjaro With High Blood Pressure?

Step 1: Does high blood pressure count as a qualifying condition for Mounjaro?

This is a question our prescribers hear most weeks, and the answer is yes. Tirzepatide (sold in the UK as Mounjaro) is licensed for weight management in adults with a BMI of 30 or above, or in adults with a BMI of 27 to 29.9 who have at least one weight-related health condition. Hypertension sits squarely on that list of qualifying conditions.

In practice, that means someone with a BMI of 28 and confirmed high blood pressure may be eligible for Mounjaro where they would not be on BMI alone. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance, your prescriber works through this as part of the consultation. You can read more about how high your BMI has to be for Mounjaro on our dedicated eligibility page.

What the licence does not do is guarantee that every person with high blood pressure will be approved. The prescriber looks at the complete picture: your BMI, your other medications, the severity of your hypertension, and whether any contraindications apply. BMI and a qualifying condition open the door; the clinical assessment decides whether it is the right door for you right now. If you are unsure whether your situation meets the criteria, our general Mounjaro eligibility overview covers the broader picture.

Step 2: What does the trial evidence say about Mounjaro and blood pressure?

The SURMOUNT-1 trial (published in the New England Journal of Medicine and involving 2,539 adults with obesity) showed that tirzepatide produced substantial average weight reductions of around 20–21% at the 15mg dose over 72 weeks. Alongside that, participants saw clinically meaningful reductions in systolic blood pressure. Weight and blood pressure are closely linked; as body weight falls, blood pressure tends to follow.

This does not mean Mounjaro is a blood-pressure treatment in its own right. Its UK licence is for weight management. But for people whose high blood pressure is driven or worsened by excess weight, the two benefits can move in the same direction. Your GP or cardiologist (whoever manages your hypertension) may want to monitor your readings more closely as your weight changes, because your antihypertensive dose may need adjusting over time.

If you are also managing chronic kidney disease alongside high blood pressure, those interact with treatment decisions in specific ways; our page on Mounjaro and CKD goes into that in more detail.

Step 3: What about the blood pressure medicines you are already taking?

Mounjaro itself does not have a direct pharmacological interaction with most common antihypertensive drugs, ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, and thiazide diuretics are not contraindicated. The interaction risk is more indirect. As weight falls and blood pressure comes down, medicines that were calibrated for a higher blood pressure may become relatively too strong, raising the risk of hypotension (blood pressure dropping too low), dizziness, or falls.

There is also the question of how Mounjaro slows gastric emptying, which affects the absorption timing of orally taken medicines. For most blood pressure drugs this is unlikely to cause a clinically significant problem, but it is something your prescriber considers. Our dedicated page on taking Mounjaro alongside blood pressure medication covers the specific drugs in more detail.

The practical upshot: tell your prescriber about every medicine you take, including over-the-counter drugs and supplements. If you are taking NMN alongside your other supplements, for example, our page on whether NMN can be combined with Mounjaro is worth reading before your consultation. At nume, your full medication list is part of every consultation review, not a box-tick but a genuine clinical check. For context on how treatment is priced and what the consultation includes, the Mounjaro pricing page lays that out plainly.

Step 4: What happens to your blood pressure monitoring during treatment?

Starting Mounjaro does not replace your existing blood pressure management, it sits alongside it. If your GP prescribes your antihypertensives, letting them know you are starting Mounjaro is sensible. This aligns with NHS guidance on tirzepatide, which recommends keeping your healthcare team informed. At nume, our prescriber notifies your GP in line with GPhC guidance as standard practice.

A few things worth knowing as treatment progresses. Blood pressure can fall faster than expected in the first weeks, particularly if nausea reduces your food and fluid intake. Stay hydrated. If you feel lightheaded, dizzy, or notice readings well below your usual range, contact your GP or the aftercare team before adjusting any medication yourself. Do not stop or reduce your antihypertensives without clinical advice, that decision belongs with whoever manages your blood pressure, guided by your actual readings.

Repeat prescriptions at nume include a clinical re-review every time. If your weight, blood pressure or general health picture changes materially, that feeds into whether and how treatment continues. Ready to have your situation properly assessed? Speak to our prescribers through a free consultation and get a same-day clinical review.